|

August 23, 2010
Pharmalucence Mebrofenin amended labeling approved by FDA, post-reconstitution expiry extended to 18 hours. Click here for details: PDF
Click here to view posting on Daily Med web site:
dailymed.nlm.nih.gov/dailymed/drugInfo.cfm
August 19, 2010
Dear Healthcare Professional Letter; Pulmolite Lot 160034
Click here for details: PDF
August 5, 2010
Pharmalucence Announces Drug Recall on DTPA Kit for the Preparation of Technetium Tc99m Pentetate Injection, Lots 2414, 2416 Click here for details: PDF
July 22, 2010
Pharmalucence Announces Drug Recall on Pulmolite® Kit for the Preparation of Technetium Tc99m Albumin Aggregated for Injection, Lot 160034
Click here for details: PDF
June 3, 2010
Pharmalucence Announces Purchase of New Property in Billerica MA, to be Developed into New Corporate Headquarters and State-of-the-Art Drug
Manufacturing Facility, beginning Summer 2010.
COME SEE US IN 2010:
ASNC: The 2010 American Society of Nuclear Cardiology Annual Meeting
September 23-25, Philadelphia PA.
Booth: 214
www.asnc.org/asnc2010
UPPI: The UPPI Annual Member Meeting
September 29-October 3, Las Vegas NV.

|